Report Detail

Pharma & Healthcare COVID-19 Impact on Global Human Hepatitis B Immunoglobulin (IM), Market Insights and Forecast to 2026

  • RnM4081758
  • |
  • 29 June, 2020
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Human Hepatitis B Immunoglobulin (IM) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Human Hepatitis B Immunoglobulin (IM) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size Growth Rate by Type
    • 1.4.2 100IU/Bottle Human Hepatitis B Immunoglobulin (IM)
    • 1.4.3 200IU/Bottle Human Hepatitis B Immunoglobulin (IM)
    • 1.4.4 400IU/Bottle Human Hepatitis B Immunoglobulin (IM)
  • 1.5 Market by Application
    • 1.5.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size Growth Rate by Application
    • 1.5.2 Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
    • 1.5.3 Unexpected Crowd of Hepatitis B Infection
    • 1.5.4 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
  • 1.6 Coronavirus Disease 2019 (Covid-19): Human Hepatitis B Immunoglobulin (IM) Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Human Hepatitis B Immunoglobulin (IM) Industry
      • 1.6.1.1 Human Hepatitis B Immunoglobulin (IM) Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Human Hepatitis B Immunoglobulin (IM) Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Human Hepatitis B Immunoglobulin (IM) Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size Estimates and Forecasts
    • 2.1.1 Global Human Hepatitis B Immunoglobulin (IM) Revenue 2015-2026
    • 2.1.2 Global Human Hepatitis B Immunoglobulin (IM) Sales 2015-2026
  • 2.2 Human Hepatitis B Immunoglobulin (IM) Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Human Hepatitis B Immunoglobulin (IM) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Human Hepatitis B Immunoglobulin (IM) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Human Hepatitis B Immunoglobulin (IM) Competitor Landscape by Players

  • 3.1 Human Hepatitis B Immunoglobulin (IM) Sales by Manufacturers
    • 3.1.1 Human Hepatitis B Immunoglobulin (IM) Sales by Manufacturers (2015-2020)
    • 3.1.2 Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Human Hepatitis B Immunoglobulin (IM) Revenue by Manufacturers
    • 3.2.1 Human Hepatitis B Immunoglobulin (IM) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Human Hepatitis B Immunoglobulin (IM) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Human Hepatitis B Immunoglobulin (IM) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Human Hepatitis B Immunoglobulin (IM) Revenue in 2019
    • 3.2.5 Global Human Hepatitis B Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Human Hepatitis B Immunoglobulin (IM) Price by Manufacturers
  • 3.4 Human Hepatitis B Immunoglobulin (IM) Manufacturing Base Distribution, Product Types
    • 3.4.1 Human Hepatitis B Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Human Hepatitis B Immunoglobulin (IM) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Human Hepatitis B Immunoglobulin (IM) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size by Type (2015-2020)
    • 4.1.1 Global Human Hepatitis B Immunoglobulin (IM) Sales by Type (2015-2020)
    • 4.1.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue by Type (2015-2020)
    • 4.1.3 Human Hepatitis B Immunoglobulin (IM) Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Type (2021-2026)
    • 4.2.3 Human Hepatitis B Immunoglobulin (IM) Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Human Hepatitis B Immunoglobulin (IM) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Human Hepatitis B Immunoglobulin (IM) Market Size by Application (2015-2020)
    • 5.1.1 Global Human Hepatitis B Immunoglobulin (IM) Sales by Application (2015-2020)
    • 5.1.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue by Application (2015-2020)
    • 5.1.3 Human Hepatitis B Immunoglobulin (IM) Price by Application (2015-2020)
  • 5.2 Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Human Hepatitis B Immunoglobulin (IM) Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Human Hepatitis B Immunoglobulin (IM) by Country
    • 6.1.1 North America Human Hepatitis B Immunoglobulin (IM) Sales by Country
    • 6.1.2 North America Human Hepatitis B Immunoglobulin (IM) Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
  • 6.3 North America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Human Hepatitis B Immunoglobulin (IM) by Country
    • 7.1.1 Europe Human Hepatitis B Immunoglobulin (IM) Sales by Country
    • 7.1.2 Europe Human Hepatitis B Immunoglobulin (IM) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
  • 7.3 Europe Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Human Hepatitis B Immunoglobulin (IM) by Region
    • 8.1.1 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales by Region
    • 8.1.2 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
  • 8.3 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Human Hepatitis B Immunoglobulin (IM) by Country
    • 9.1.1 Latin America Human Hepatitis B Immunoglobulin (IM) Sales by Country
    • 9.1.2 Latin America Human Hepatitis B Immunoglobulin (IM) Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
  • 9.3 Central & South America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) by Country
    • 10.1.1 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales by Country
    • 10.1.2 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Type
  • 10.3 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Baxter
    • 11.1.1 Baxter Corporation Information
    • 11.1.2 Baxter Description, Business Overview and Total Revenue
    • 11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Baxter Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.1.5 Baxter Recent Development
  • 11.2 CSL
    • 11.2.1 CSL Corporation Information
    • 11.2.2 CSL Description, Business Overview and Total Revenue
    • 11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 CSL Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.2.5 CSL Recent Development
  • 11.3 Bayer
    • 11.3.1 Bayer Corporation Information
    • 11.3.2 Bayer Description, Business Overview and Total Revenue
    • 11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Bayer Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.3.5 Bayer Recent Development
  • 11.4 Grifols
    • 11.4.1 Grifols Corporation Information
    • 11.4.2 Grifols Description, Business Overview and Total Revenue
    • 11.4.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Grifols Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.4.5 Grifols Recent Development
  • 11.5 Octapharma
    • 11.5.1 Octapharma Corporation Information
    • 11.5.2 Octapharma Description, Business Overview and Total Revenue
    • 11.5.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Octapharma Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.5.5 Octapharma Recent Development
  • 11.6 Shanghai RAAS
    • 11.6.1 Shanghai RAAS Corporation Information
    • 11.6.2 Shanghai RAAS Description, Business Overview and Total Revenue
    • 11.6.3 Shanghai RAAS Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.6.5 Shanghai RAAS Recent Development
  • 11.7 Hualan Biological
    • 11.7.1 Hualan Biological Corporation Information
    • 11.7.2 Hualan Biological Description, Business Overview and Total Revenue
    • 11.7.3 Hualan Biological Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Hualan Biological Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.7.5 Hualan Biological Recent Development
  • 11.8 China Biologic
    • 11.8.1 China Biologic Corporation Information
    • 11.8.2 China Biologic Description, Business Overview and Total Revenue
    • 11.8.3 China Biologic Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 China Biologic Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.8.5 China Biologic Recent Development
  • 11.9 Tiantan Biologic
    • 11.9.1 Tiantan Biologic Corporation Information
    • 11.9.2 Tiantan Biologic Description, Business Overview and Total Revenue
    • 11.9.3 Tiantan Biologic Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.9.5 Tiantan Biologic Recent Development
  • 11.10 Shuanglin Bio-pharmacy
    • 11.10.1 Shuanglin Bio-pharmacy Corporation Information
    • 11.10.2 Shuanglin Bio-pharmacy Description, Business Overview and Total Revenue
    • 11.10.3 Shuanglin Bio-pharmacy Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.10.5 Shuanglin Bio-pharmacy Recent Development
  • 11.1 Baxter
    • 11.1.1 Baxter Corporation Information
    • 11.1.2 Baxter Description, Business Overview and Total Revenue
    • 11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Baxter Human Hepatitis B Immunoglobulin (IM) Products Offered
    • 11.1.5 Baxter Recent Development
  • 11.12 Boya Bio-pharmaceutical
    • 11.12.1 Boya Bio-pharmaceutical Corporation Information
    • 11.12.2 Boya Bio-pharmaceutical Description, Business Overview and Total Revenue
    • 11.12.3 Boya Bio-pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Boya Bio-pharmaceutical Products Offered
    • 11.12.5 Boya Bio-pharmaceutical Recent Development
  • 11.13 Shanghai Institute of Biological
    • 11.13.1 Shanghai Institute of Biological Corporation Information
    • 11.13.2 Shanghai Institute of Biological Description, Business Overview and Total Revenue
    • 11.13.3 Shanghai Institute of Biological Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Shanghai Institute of Biological Products Offered
    • 11.13.5 Shanghai Institute of Biological Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Human Hepatitis B Immunoglobulin (IM) Market Estimates and Projections by Region
    • 12.1.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
    • 12.2.2 North America: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Human Hepatitis B Immunoglobulin (IM) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Human Hepatitis B Immunoglobulin (IM) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Human Hepatitis B Immunoglobulin (IM) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Human Hepatitis B Immunoglobulin (IM) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Human Hepatitis B Immunoglobulin (IM) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Human Hepatitis B Immunoglobulin (IM) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Hepatitis B Immunoglobulin (IM) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Human Hepatitis B Immunoglobulin (IM) market is segmented into
    100IU/Bottle Human Hepatitis B Immunoglobulin (IM)
    200IU/Bottle Human Hepatitis B Immunoglobulin (IM)
    400IU/Bottle Human Hepatitis B Immunoglobulin (IM)

    Segment by Application, the Human Hepatitis B Immunoglobulin (IM) market is segmented into
    Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
    Unexpected Crowd of Hepatitis B Infection
    Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers

    Regional and Country-level Analysis
    The Human Hepatitis B Immunoglobulin (IM) market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Human Hepatitis B Immunoglobulin (IM) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Human Hepatitis B Immunoglobulin (IM) Market Share Analysis
    Human Hepatitis B Immunoglobulin (IM) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Hepatitis B Immunoglobulin (IM) business, the date to enter into the Human Hepatitis B Immunoglobulin (IM) market, Human Hepatitis B Immunoglobulin (IM) product introduction, recent developments, etc.
    The major vendors covered:
    Baxter
    CSL
    Bayer
    Grifols
    Octapharma
    Shanghai RAAS
    Hualan Biological
    China Biologic
    Tiantan Biologic
    Shuanglin Bio-pharmacy
    Sichuan Yuanda Shuyang
    Boya Bio-pharmaceutical
    Shanghai Institute of Biological


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Human Hepatitis B Immunoglobulin (IM). Industry analysis & Market Report on COVID-19 Impact on Global Human Hepatitis B Immunoglobulin (IM) is a syndicated market report, published as COVID-19 Impact on Global Human Hepatitis B Immunoglobulin (IM), Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Human Hepatitis B Immunoglobulin (IM) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,129.35
    4,694.03
    6,258.70
    3,470.83
    5,206.25
    6,941.66
    419,320.20
    628,980.30
    838,640.40
    291,355.74
    437,033.61
    582,711.48
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report